卵母细胞捐赠妊娠的合并症、危险因素及母儿结局
回顾性单中心队列研究分析2009至2017年意大利佛罗伦萨Careggi大学医院25,851例单胎分娩,其中卵母细胞捐赠276例、IVF/ICSI 925例、自然妊娠24,650例。卵母细胞捐赠组年龄更大、慢性高血压患病率高于自然妊娠组,妊娠期高血压、剖宫产、产后出血、早产和低出生体重风险均升高。
要点
- 卵母细胞捐赠妊娠者年龄更大,慢性高血压患病率高于自然妊娠组(P=0.0090)。
- 妊娠期高血压风险较自然妊娠高(aOR 3.6)、较IVF/ICSI高(aOR 2.7)。
- 产后出血风险约为自然妊娠的11倍、约为IVF/ICSI的近4倍。
核心结论
- 卵母细胞捐赠妊娠者合并症及不良产科结局危险因素增多。
- 卵母细胞捐赠似乎独立关联妊娠期高血压和产后出血。
- 卵母细胞捐赠妊娠需临床监测并适当筛查,可能需预防策略。
研究设计与样本
- 回顾性单中心当代队列研究,纳入2009至2017年佛罗伦萨Careggi大学医院单胎分娩。
- 共25,851例妊娠及新生儿:卵母细胞捐赠276例(1.1%)、IVF/ICSI 925例(3.6%)、自然妊娠24,650例(95.4%)。
- 分析母亲及围产结局。
主要发现
- 卵母细胞捐赠组年龄显著大于IVF/ICSI组和自然妊娠组(P<0.0001)。
- 慢性高血压患病率高于自然妊娠组(P=0.0090)。
- 妊娠期高血压发生率高于自然妊娠(aOR 3.6)和IVF/ICSI(aOR 2.7)。
- 剖宫产率高于自然妊娠(aOR 3.4)和IVF/ICSI(aOR 2.3)。
- 产后出血风险约为自然妊娠的11倍、约为IVF/ICSI的近4倍;早产和低出生体重较自然妊娠更常见(aOR 2.4和1.8)。
临床怎么用
- 原文结论指出卵母细胞捐赠妊娠需临床监测并适当筛查,可能需预防策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: To evaluate pre-existing comorbidities, obstetric risk factors and adverse obstetric and neonatal outcomes in pregnancies conceived by oocyte donation, compared with naturally conceived pregnancies or by conventional IVF/intracytoplasmic sperm injection (IVF/ICSI). DESIGN: This retrospective single-centre contemporary cohort study reviewed data from singleton deliveries at the University Hospital of Careggi, Florence, from 2009 to 2017. Maternal and perinatal outcomes were analysed. RESULTS: The study included 25,851 pregnancies and newborns: 276 (1.1%) children were conceived after oocyte donation, 925 (3.6%) after IVF/ICSI and 24,650 (95.4%) after natural conception. Women in the oocyte donation group were significantly older compared with IVF/ICSI and natural conception groups (P < 0.0001) and had a higher prevalence of chronic hypertension compared with the natural conception group (P = 0.0090). They were administered anticoagulant medications more frequently during pregnancy. The incidence of gestational hypertension was significantly higher than in natural conception (aOR 3.6) and IVF/ICSI pregnancies (aOR 2.7). The incidence of Caesarean section in oocyte donation pregnancies was higher than in natural conception and IVF/ICSI groups (aOR 3.4 and 2.3, respectively). An 11-fold increased risk of post-partum haemorrhage (PPH) was found in oocyte donation versus natural conception and an almost four-fold increased risk was found in oocyte donation versus IVF/ICSI; prematurity and low birthweight were more frequent after oocyte donation versus natural conception (aOR 2.4 and 1.8, respectively). CONCLUSIONS: Patients undergoing oocyte donation represent a group with increased comorbidities and risk factors for adverse obstetric outcomes. Oocyte donation seems to be independently associated with gestational hypertension and PPH. Pregnancies after oocyte donation warrant clinical surveillance with proper screening and, possibly, preventive strategies.
引用
- Rizzello F, Coccia ME, Fatini C, et al. Comorbidities, risk factors and maternal/perinatal outcomes in oocyte donation pregnancies. Reprod Biomed Online. 2020. PMID: 32576492. doi:10.1016/j.rbmo.2020.04.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。